search icon
Join IDSAJOIN IDSA >> Go to MyIDSAGO TO MYIDSA >>
  • Print
  • ShareThis
  • Text Size

FDA approves new drug for bacterial vaginosis

Monday, September 18, 2017 11:49AM

Today FDA approved a new medication for bacterial vaginosis. This treatment is the first one-dose oral regimen for the most common vaginal infection in women 15-44 years of age.

To learn more, please visit: Solosec.

 

Additional Information

  • For additional drug information, please visit the DDI Web page.
  • For up-to-date drug information, follow the FDA’s Division of Drug Information on Twitter: FDA_Drug_Info.

 

| HIVMA | Contact Us

© Copyright IDSA 2017 Infectious Diseases Society of America

Full Site Mobile Site